Covidien PLC (COV) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
20 ON HATCH DUBLIN, DUBLIN 2 |
| State of Incorp. | |
| Fiscal Year End | September 30 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 9/30/2014 | 9/30/2013 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 1,868 | |||
| Cash and cash equivalents | 1,868 | |||
| Receivables | 1,526 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,352 | |||
| Inventory | 1,352 | |||
| Derivative instruments and hedges, assets | ||||
| Income taxes receivable | 62 | |||
| Other undisclosed current assets | 1,059 | |||
| Total current assets: | 5,867 | |||
| Noncurrent Assets | ||||
| Property, plant and equipment | 2,012 | |||
| Intangible assets, net (including goodwill) | 10,859 | |||
| Goodwill | 8,172 | |||
| Intangible assets, net (excluding goodwill) | 2,687 | |||
| Other noncurrent assets | 805 | |||
| Other undisclosed noncurrent assets | 375 | |||
| Total noncurrent assets: | 14,051 | |||
| TOTAL ASSETS: | 19,918 | |||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,616 | |||
| Taxes payable | 689 | |||
| Employee-related liabilities | 426 | |||
| Accounts payable | 501 | |||
| Debt | 11 | |||
| Derivative instruments and hedges, liabilities | ||||
| Other liabilities | 1,586 | |||
| Deferred tax liabilities | 5 | |||
| Other undisclosed current liabilities | (579) | |||
| Total current liabilities: | 2,639 | |||
| Noncurrent Liabilities | ||||
| Long-term debt and lease obligation, including: | 5,018 | |||
| Other undisclosed long-term debt and lease obligation | 5,018 | |||
| Liabilities, other than long-term debt | 2,461 | |||
| Accrued income taxes | 1,147 | |||
| Deferred tax liabilities, net | 605 | |||
| Restructuring reserve | 13 | |||
| Other liabilities | 696 | |||
| Other undisclosed noncurrent liabilities | 558 | |||
| Total noncurrent liabilities: | 8,037 | |||
| Total liabilities: | 10,676 | |||
| Temporary equity, carrying amount | ||||
| Equity | ||||
| Equity, attributable to parent | 9,242 | |||
| Common stock | 97 | |||
| Treasury stock, value | (2,210) | |||
| Additional paid in capital | 7,549 | |||
| Accumulated other comprehensive income | 292 | |||
| Retained earnings | 3,514 | |||
| Total equity: | 9,242 | |||
| TOTAL LIABILITIES AND EQUITY: | 19,918 | |||
Income Statement (P&L) ($ in millions)
| 9/30/2014 | 9/30/2013 | ||
|---|---|---|---|
| Revenues (Revenue, Net) | 10,235 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (4,150) | ||
| Gross profit: | 6,085 | ||
| Operating expenses | (4,175) | ||
| Other undisclosed operating income | 222 | ||
| Operating income: | 2,132 | ||
| Nonoperating income (expense) | 5 | ||
| Investment income, nonoperating | 16 | ||
| Loss, foreign currency transaction, before tax | (32) | ||
| Other nonoperating income | 89 | ||
| Interest and debt expense | (228) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 120 | ||
| Income from continuing operations before income taxes: | 2,029 | ||
| Income tax expense | (429) | ||
| Income from continuing operations: | 1,600 | ||
| Income before gain (loss) on sale of properties: | 1,600 | ||
| Net income: | 1,600 | ||
| Other undisclosed net income attributable to parent | 100 | ||
| Net income available to common stockholders, diluted: | 1,700 | ||
Comprehensive Income ($ in millions)
| 9/30/2014 | 9/30/2013 | ||
|---|---|---|---|
| Net income: | 1,600 | ||
| Comprehensive income: | 1,600 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 72 | ||
| Comprehensive income, net of tax, attributable to parent: | 1,672 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.